We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Disease treatment drugs.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Disease treatment drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Disease treatment drugs Product List

1～18 item / All 18 items

Displayed results
Tohoku University Technology: Treatment and Prevention Agents for Chronic Kidney Disease Complications: T22-116

Tohoku University Technology: Treatment and Prevention Agents for Chronic Kidney Disease Complications: T22-116

Components found in mammalian milk suppress the progression of kidney disorders, sarcopenia, and anemia.

Chronic kidney disease currently affects about 1 in 8 adults and is said to be a new national disease in Japan. The treatment aims to slow the progression of symptoms, particularly to prevent the progression to end-stage renal failure and the onset of cardiovascular diseases. CKD also has complications such as bone disorders, muscle atrophy (sarcopenia), and anemia, and there are no effective treatments available. This invention relates to the effects of a protein called lactoferrin (Lf) on the progression and complications of chronic kidney disease (CKD). It was found that the administration of Lf has both preventive effects before the onset of CKD and therapeutic effects after its onset in adenine-induced renal failure model mice (Reference 1). Specifically, the effects of Lf in suppressing sarcopenia (reduction of muscle cross-sectional area, decrease in the accumulation of uremic toxins in muscles), anemia, renal atrophy, tubular interstitial damage, decline in kidney function, and inflammation and fibrosis in the kidneys were confirmed.

  • others
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku Univ. Technology : Renal function improving agent : T13-090

Tohoku Univ. Technology : Renal function improving agent : T13-090

Drug repositioning of Lubiprostone Exploratory P2 is over!

Toxin adsorbents such as SGLT2 inhibitors and cremedin have been used as pharmacotherapy for kidney disease. Lubiprostone, which is also used as a constipation drug, was shown to be effective as a treatment for chronic kidney disease (CKD). Lubiprostone was also found to suppress the decline in renal function. In an investigator-initiated clinical trial, the inventors conducted an exploratory study to investigate the efficacy and safety of 8 μg/day and 16 μg/day of lubiprostone in reducing renal function in patients with chronic kidney disease, using a placebo control. (The results can be disclosed under individual contracts.)

  • others
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Krabbe Disease Treatments

[Research Material] The Global Market for Krabbe Disease Treatments

Global Market for Krabbe Disease Treatments: Anticonvulsants, Muscle Relaxants, Others, Hospitals, Clinics, Research Centers, Others

This research report (Global Krabbe Disease Drugs Market) investigates and analyzes the current status and outlook for the global market for Krabbe disease treatment drugs over the next five years. It includes information on the overview of the global Krabbe disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Krabbe disease treatment drug market include anticonvulsants, muscle relaxants, and others, while the segments by application cover hospitals, clinics, research centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Krabbe disease treatment drugs. It also includes the market share of major companies in the Krabbe disease treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Crohn's Disease Treatment Drugs

[Research Material] Global Market for Crohn's Disease Treatment Drugs

World Market for Crohn's Disease Treatments: Aminosalicylates (5-ASA), Corticosteroids, Immunomodulators, Antibiotics, Achievement of Remission (Absence of Symptoms ...

This research report (Global Crohn’s Disease Drug Market) investigates and analyzes the current state and future outlook of the global market for Crohn's disease treatment drugs over the next five years. It includes information on the overview of the global Crohn's disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include aminosalicylates (5-ASA), corticosteroids, immunomodulators, and antibiotics, while the segments by application focus on achieving remission (absence of symptoms), maintaining remission (preventing relapse), and pediatric Crohn's disease. The regional segments calculate the market size for Crohn's disease treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Crohn's disease treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] World Market for Rabies Treatment

[Research Material] World Market for Rabies Treatment

World Market for Rabies Treatment: Cell Culture Vaccines (CCV), Rabies Immunoglobulin (RIG), Nerve Tissue Vaccines (NTV), Pre-Exposure Prophylaxis ...

This research report (Global Rabies Treatment Market) investigates and analyzes the current state and outlook for the global rabies treatment market over the next five years. It includes information on the overview of the global rabies treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rabies treatment market focus on cell culture vaccines (CCV), rabies immunoglobulin (RIG), and nerve tissue vaccines (NTV), while the segments by application target pre-exposure prophylaxis and post-exposure prophylaxis. The regional segments calculate the market size for rabies treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in rabies treatment, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Celiac Disease Treatments

[Research Material] Global Market for Celiac Disease Treatments

Celiac disease treatment market worldwide: primary treatment, secondary treatment, hospitals, research

This research report (Global Celiac Disease Drugs Market) investigates and analyzes the current status and outlook for the global market for celiac disease treatment drugs over the next five years. It includes information on the overview of the global celiac disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on primary and secondary treatments, while the segments by application target hospitals and research. The regional segments calculate the market size for celiac disease treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the celiac disease treatment drug market, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Wilson's Disease Treatment

[Research Material] The Global Market for Wilson's Disease Treatment

Global Market for Wilson's Disease Treatment: D-Penicillamine, Trientine, Tetrathiomolybdate, Others, Hospitals, Clinics, Others

This research report (Global Wilson's Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for Wilson's disease treatment over the next five years. It includes information on the overview of the global Wilson's disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Wilson's disease treatment market include D-penicillamine, trientine, tetrathiomolybdate, and others, while the segments by application include hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Wilson's disease treatment. It also includes the market share of major companies in Wilson's disease treatment, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Hansen's Disease Treatment

[Research Material] The Global Market for Hansen's Disease Treatment

World Market for Hansen's Disease Treatment: Sulfones, Phenazine Derivatives, Antituberculosis Drugs, Others, Hospitals, Clinics, Pharmacies

This research report (Global Leprosy Treatment Market) investigates and analyzes the current state and outlook for the global leprosy treatment market over the next five years. It includes information on the overview of the global leprosy treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the leprosy treatment market include sulfone, phenazine derivatives, anti-tubular drugs, and others, while the segments by application focus on hospitals, clinics, and pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for leprosy treatment. It also includes the market share of major companies in leprosy treatment, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Chagas Disease Treatments

[Research Material] The Global Market for Chagas Disease Treatments

World Market for Chagas Disease Treatments: Cz-007, Cz-008, D-121, DNDI-0690, EPLBS-1246, EPLB ...

This research report (Global Chagas Disease Drug Market) investigates and analyzes the current status and outlook for the global market for Chagas disease treatment drugs over the next five years. It includes information on the overview of the global Chagas disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Cz-007, Cz-008, D-121, DNDI-0690, EPLBS-1246, EPLBS-967, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments calculate the market size for Chagas disease treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Chagas disease treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Castleman Disease Treatment

[Research Material] The Global Market for Castleman Disease Treatment

Global Market for Castleman Disease Treatment: Monoclonal Antibodies, Chemotherapy, Radiation Therapy, Immunotherapy, Corticosteroids, Antiviral Drugs, Disease ...

This research report (Global Castleman Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for Castleman disease treatment over the next five years. It includes information on the overview of the global Castleman disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Castleman disease treatment market include monoclonal antibodies, chemotherapy, radiation therapy, immunotherapy, corticosteroids, and antiviral drugs, while the segments by application focus on hospitals, clinics, and outpatient units. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Castleman disease treatment. It also includes the market share of major companies in Castleman disease treatment, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gaucher Disease (GD) Treatments

[Research Material] Global Market for Gaucher Disease (GD) Treatments

Global Market for Gaucher Disease (GD) Treatments: Enzyme Replacement Therapy, Substrate Reduction Therapy, Non-Neuropathic Gaucher Disease, Neuropathic Gaucher Disease

This research report (Global Gaucher Disease (GD) Drugs Market) investigates and analyzes the current status and future outlook of the global market for Gaucher disease (GD) treatment drugs over the next five years. It includes information on the overview of the global Gaucher disease (GD) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Gaucher disease (GD) treatment drugs by type include enzyme replacement therapy and substrate reduction therapy, while the segments by application focus on non-neuropathic Gaucher disease and neuropathic Gaucher disease. The regional segments calculate the market size for Gaucher disease (GD) treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Gaucher disease (GD) treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Alzheimer's Disease Treatments

[Research Material] The Global Market for Alzheimer's Disease Treatments

World Market for Alzheimer's Disease Treatments: Donepezil, Memantine, Rivastigmine, Early to Moderate Stage, Moderate to Severe Stage

This research report (Global Alzheimer’s Therapeutics Market) investigates and analyzes the current state and outlook for the global market for Alzheimer’s disease treatments over the next five years. It includes information on the overview of the global Alzheimer’s disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Donepezil, Memantine, and Rivastigmine, while the segments by application focus on early to moderate stages and moderate to severe stages. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Alzheimer’s disease treatments. It also includes the market share of major companies in Alzheimer’s disease treatments, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Lyme Disease Treatment Market

[Market Report] Global Lyme Disease Treatment Market

The global Lyme disease treatment market is expected to achieve steady growth, reaching 1.652 billion USD by 2031.

The global Lyme disease treatment market is aiming for significant expansion, with revenues reaching approximately $799.4 million in 2022. Recent market analysis indicates that this sector is expected to experience a robust compound annual growth rate (CAGR) of 8.4% in 2022. The forecast period is from 2023 to 2031, with an estimated value of $1.652 billion by 2031. This increase is attributed to the rising global prevalence of Lyme disease and the development of innovative treatments. As the prevalence of Lyme disease continues to rise and research efforts focus on developing more effective treatment options, the global Lyme disease treatment market is poised for continuous growth. Increased investment in research and development, expanded access to healthcare, and heightened awareness of Lyme disease among healthcare professionals and the general public are expected to lead to significant advancements in the diagnosis and treatment of this debilitating disease. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gaucher Disease Treatment Drugs

[Research Material] Global Market for Gaucher Disease Treatment Drugs

Global Market for Gaucher Disease Treatments: Enzymes, Glucosylceramide Synthase Inhibitors, Osteoporosis Drugs, Type I Gaucher Disease, Type II Gaucher Disease, II ...

This research report (Global Gaucher Disease Drugs Market) investigates and analyzes the current status and outlook for the global market of Gaucher disease treatment drugs over the next five years. It includes information on the overview of the global Gaucher disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Gaucher disease treatment drug market focus on enzymes, glucocerebrosidase inhibitors, and osteoporosis drugs, while the segments by application target Type I Gaucher disease, Type II Gaucher disease, and Type III Gaucher disease. The regional segments calculate the market size for Gaucher disease treatment drugs by dividing into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Gaucher disease treatment drugs, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Paget's Disease Treatment

[Research Material] Global Market for Paget's Disease Treatment

World Market for Paget's Disease Treatment: Bisphosphonates, Calcitonin Analogues (Salmon Calcitonin), Analgesics, Calcium and Vitamin ...

This research report (Global Paget's Disease Treatment Market) investigates and analyzes the current status and outlook for the global market for Paget's disease treatment over the next five years. It includes information on the overview of the global Paget's disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Paget's disease treatment market include bisphosphonates, calcitonin analogs (salmon calcitonin), analgesics, and calcium and vitamin D supplements, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Paget's disease treatment. It also includes the market share of major companies in Paget's disease treatment, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Parkinson's Disease (PD) Treatments

[Research Material] Global Market for Parkinson's Disease (PD) Treatments

Global Market for Parkinson's Disease (PD) Treatments: Dopamine Agonists, Monoamine Oxidase Inhibitors, Acetylcholinesterase Inhibitors, etc.

This research report (Global Parkinson's Disease (PD) Drugs Market) investigates and analyzes the current state and future outlook of the global market for Parkinson's disease (PD) treatment drugs over the next five years. It includes information on the overview of the global Parkinson's disease (PD) treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Parkinson's disease (PD) treatment drugs by type include dopamine agonists, monoamine oxidase inhibitors, acetylcholinesterase inhibitors, and glutamate inhibitors, while the segments by application focus on hospitals and families. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Parkinson's disease (PD) treatment drugs. The report also includes the market share of major companies in the Parkinson's disease (PD) treatment drugs sector, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Gaucher Disease Treatment

[Research Material] The Global Market for Gaucher Disease Treatment

Global Market for Gaucher Disease Treatment: Type 1 (Neuropathic Form), Type 2 (Perinatal Lethal Form), Type 3 (Late Neuropathic Collapse Form), Hospitals, Out ...

This research report (Global Gaucher Disease Treatment Market) investigates and analyzes the current status and outlook for the global market for Gaucher disease treatment over the next five years. It includes information on the overview of the global Gaucher disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Gaucher disease treatment market focus on Type 1 (neuronopathic form), Type 2 (perinatal lethal form), and Type 3 (late neuronopathic form), while the segments by application target hospitals, outpatient surgical centers, and clinical laboratories. The regional segments calculate the market size for Gaucher disease treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Gaucher disease treatment, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for von Willebrand Disease (VWD) Treatments

[Research Material] The Global Market for von Willebrand Disease (VWD) Treatments

World Market for Von Willebrand Disease (VWD) Treatments: Desmopressin, Thrombus Stabilization Drugs, Fibrinolysis Inhibitors, Replacement Therapy, Others, Hospitals ...

This research report (Global Von Willebrand Disease (VWD) Therapeutics M) investigates and analyzes the current status and outlook for the global market of Von Willebrand disease (VWD) therapeutics over the next five years. It includes information on the overview of the global Von Willebrand disease (VWD) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for Von Willebrand disease (VWD) therapeutics include desmopressin, thrombin stabilizers, fibrinolysis inhibitors, replacement therapy, and others, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for Von Willebrand disease (VWD) therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Von Willebrand disease (VWD) therapeutics, product and business overviews, and sales performance.

  • Other services
  • Disease treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Disease treatment drugs

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.